Surfactant replacement therapy--room for improvement.
作者信息
Mason R J
出版信息
West J Med. 1995 Jan;162(1):74-6.
Abstract
摘要
相似文献
1
Surfactant replacement therapy--room for improvement.表面活性剂替代疗法——仍有改进空间。
West J Med. 1995 Jan;162(1):74-6.
2
3
Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.合成表面活性剂与人类表面活性剂治疗呼吸窘迫综合征的影像学表现
AJR Am J Roentgenol. 1991 Aug;157(2):371-4. doi: 10.2214/ajr.157.2.1853824.
4
5
Respiratory support in preterm infants at birth.出生时早产儿的呼吸支持。
Pediatrics. 2014 Jan;133(1):171-4. doi: 10.1542/peds.2013-3442. Epub 2013 Dec 30.
6
Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.新生儿表面活性剂替代疗法：超越呼吸窘迫综合征
Respir Care. 2009 Sep;54(9):1203-8.
7
Pulmonary surfactant.肺表面活性物质
Annu Rev Med. 1989;40:431-46. doi: 10.1146/annurev.me.40.020189.002243.
8
[Acute respiratory distress syndrome--effective therapeutic methods, at last?].[急性呼吸窘迫综合征——终于有有效的治疗方法了？]
Tidsskr Nor Laegeforen. 1996 Apr 20;116(10):1208-9.
9
Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia.经鼻持续气道正压通气及表面活性剂治疗呼吸窘迫综合征并预防支气管肺发育不良
Acta Paediatr. 2009 Sep;98(9):1400-8. doi: 10.1111/j.1651-2227.2009.01413.x. Epub 2009 Jul 1.
10
Surfactant treatment in the ICU: alternative interpretations of existing evidence.
Paediatr Anaesth. 2006 Aug;16(8):813-5. doi: 10.1111/j.1460-9592.2006.02015.x.
本文引用的文献
1
Properties, function and origin of the alveolar lining layer.肺泡衬里层的特性、功能及起源
Nature. 1955 Jun 25;175(4469):1125-6. doi: 10.1038/1751125b0.
2
PRELIMINARY REPORT. THE PULMONARY HYPOPERFUSION SYNDROME.初步报告。肺灌注不足综合征。
Pediatrics. 1965 May;35:733-42.
3
Surface properties in relation to atelectasis and hyaline membrane disease.与肺不张和透明膜病相关的表面特性
AMA J Dis Child. 1959 May;97(5, Part 1):517-23. doi: 10.1001/archpedi.1959.02070010519001.
4
Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects.肺泡表面活性物质与成人呼吸窘迫综合征。发病机制作用及治疗前景。
Clin Investig. 1993 Mar;71(3):177-90. doi: 10.1007/BF00180100.
5
Pulmonary surfactant therapy.肺表面活性物质疗法
N Engl J Med. 1993 Mar 25;328(12):861-8. doi: 10.1056/NEJM199303253281208.
6
Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis.简短报告：先天性肺泡蛋白沉积症中肺表面活性物质蛋白B缺乏
N Engl J Med. 1993 Feb 11;328(6):406-10. doi: 10.1056/NEJM199302113280606.
7
Disruption of pulmonary surfactant's ability to maintain openness of a narrow tube.肺表面活性物质维持细管开放能力的破坏。
J Appl Physiol (1985). 1993 Jun;74(6):2922-7. doi: 10.1152/jappl.1993.74.6.2922.
8
A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds.一种在多个家族中导致致命性新生儿呼吸系统疾病的表面活性蛋白B基因突变。
J Clin Invest. 1994 Apr;93(4):1860-3. doi: 10.1172/JCI117173.
9
The proteins of the surfactant system.表面活性剂系统的蛋白质。
Eur Respir J. 1994 Feb;7(2):372-91. doi: 10.1183/09031936.94.07020372.
10
Keratinocyte growth factor is a growth factor for type II pneumocytes in vivo.角质形成细胞生长因子是体内II型肺细胞的生长因子。
J Clin Invest. 1994 Mar;93(3):1298-306. doi: 10.1172/JCI117086.
Zotero 插件